Publicaciones en las que colabora con Virginia Ollero Pena (15)

2024

  1. Implementation of a Teledermatology Electronic Consultation Program to Improve the Care of Patients with Inflammatory Bowel Disease

    Telemedicine Reports, Vol. 5, Núm. 1, pp. 12-17

2022

  1. TELEIBD: A telematic fast-track pathway for patients with high suspicion of Inflammatory Bowel Disease in primary care

    JOURNAL OF CROHNS & COLITIS, Vol. 16, Núm. Supl 1, pp. I314-I315

2020

  1. The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study

    Telemedicine and e-Health, Vol. 26, Núm. 1, pp. 80-88

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

    Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854

2018

  1. N037 Attitudes of Crohn’s disease patients toward self-monitoring trough an App

    Journal of Crohn's and Colitis, Vol. 12, Núm. supplement_1, pp. S585-S585

  2. P339 Crohn’s disease and self-monitoring through a mobile App: The Medicrohn study

    Journal of Crohn's and Colitis, Vol. 12, Núm. supplement_1, pp. S273-S273

2017

  1. P186 Association between anti-TNF serum levels and mucosal healing in inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 11, Núm. suppl_1, pp. S171-S171

2015

  1. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 4, pp. 430-435

  2. P408. Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis

    Journal of Crohn's and Colitis, Vol. 9, Núm. suppl 1, pp. S283-S283

2014

  1. Drug trough levels and primary nonresponse to antiTNF therapy in moderate-severe Crohn disease

    Gastroenterology, Vol. 146, Núm. Suppl. 1, pp. 247

2011

  1. Can Early Anti-TNF Treatment Modify the Outcome of Inflammatory Strictures?

    Gastroenterology, Vol. 140, Núm. 5, pp. S-779

  2. Ileal Crohn's disease: MRI with endoscopic correlation

    European Journal of Radiology, Vol. 80, Núm. 2

  3. Imágenes en EICI

    Inflamatoria: Revista oficial del grupo EIGA, Núm. 6, pp. 30-32

2010

  1. Ulcerative colitis in northern Portugal and Galicia in Spain

    Inflammatory Bowel Diseases, Vol. 16, Núm. 7, pp. 1227-1238